Versuchen GOLD - Frei

Strategic HR for Today's Biotech M&As

Bio Spectrum

|

January 2017

The pharmaceutical and bio-technology sectors have been witnessing a strong trend of consolidation through mergers and acquisitions (M&A) over the last few years.

- Amitava Saha

Strategic HR for Today's Biotech M&As

Globally, 166 M&A deals were announced in the pharmaceutical and biotechnology sectors in 2015, up from 137 in 2014, according to The Pharma Letter. Moreover, the number of deals exceeding USD1 billion rose to 30 in 2015 versus 26 in 2014 and 20 in 2013.

Not only are the number of deals increasing, their size is going up too. The average potential deal value in the biotech sector increased to USD320 million in 2015 from USD309 million in 2014, according to a report by E&Y. In 2015, 17 of the alliances in this sector had a total potential value greater than USD1 billion versus 12 in 2014 and only five in 2013.

The reasons behind the rise in the intensity of deal making are not hard to seek. A drop in earnings due to patent expiries on blockbuster drugs, declining R&D productivity and rising pricing pressure are leading to heightened M&A activity. Moreover, US drugmakers are looking at the M&A route to cash in on the benefits of low corporate tax rates in other countries. In the biotech sector, M&As are being driven by the desire of larger biopharma players to secure access to innovative technology platforms.

Why HR is key to successful M&As

Given the mega size of these transactions, there’s more pressure than ever on company managements to ensure that M&As are consummated with as less friction as possible so that the combined entity works as a single unified team to realize the potential benefits of the merger. It is here that the Human Resources (HR) function has a key role to play. HR has the greatest impact in the process of integrating two sets of employees and their daily work processes. One of the potent ways in which HR can ensure a smooth transition to a unified entity post a M&A deal is by focusing on defining a set of desirable cultural attributes and then getting employees to quickly adopt these attributes in their daily behaviour.

WEITERE GESCHICHTEN VON Bio Spectrum

Bio Spectrum

S&T Minister inaugurates Biotechnology Research and Innovation Council (BRIC) Secretariat

The Union Minister of (Independent State Charge) for Science and Technology (S&T) Dr Jitendra Singh recently inaugurated the Biotechnology Research and Innovation Council (BRIC) Secretariat by unveiling the inaugural curtain, marking the official opening of a new milestone in India's biotechnology journey.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

US announces $50 B in awards to strengthen rural healthcare

The Centers for Medicare & Medicaid Services (CMS) has announced that all 50 states will receive awards under the Rural Health Transformation Program, a $50 billion initiative established under President Trump's Working Families Tax Cuts legislation (Public Law 119-21) to strengthen and modernise healthcare in rural communities across the country.

time to read

1 min

February 2026

Bio Spectrum

WHO unveils Traditional Medicine Global Library

At the second WHO Global Summit on Traditional Medicine, jointly organised with the Government of India, concluding recently in New Delhi, WHO unveiled the Traditional Medicine (TM) Global Library (GL), a first-of-its-kind digital platform consolidating 1.6 million resources on TM, from scientific studies to indigenous knowledge.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Telangana sets global ambition with Life Sciences Policy 2026-30 targeting $25 B investments

The Government of Telangana unveiled its Next-Gen Life Sciences Policy 2026-30 at the World Economic Forum Annual Meeting in Davos, signalling the State's intent to play a far more consequential role in shaping the future of global healthcare, advanced therapeutics, and sustainable bio-manufacturing.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

WHO reveals major equity gaps in human genomics research

The World Health Organization (WHO) has published a new global analysis of human genomics in clinical research, covering more than three decades of studies registered between 1990 and 2024.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Biotium launches GlycoLiner Cell Surface Glycoprotein Labeling Kits

US-based Biotium, a leading innovator in fluorescent dyes and life science reagents, has announced the launch of GlycoLiner Cell Surface Glycoprotein Labeling Kits for rapid, selective, and covalent labeling of cell surface glycoproteins.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Bruker consolidates ownership of TOFWERK in expansion of mass spectrometry portfolio

Bruker Corporation has announced the acquisition of an additional 60 per cent ownership stake in TOFWERK AG, a Switzerland-based innovator in ultra-fast time-of-flight (TOF) mass spectrometry technology for small molecule applied markets, consolidating Bruker's ownership to 100 per cent.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

India & Australia develop precision nano-injection platform for breast cancer drug delivery

Researchers from the Indian Institute of Technology Madras (IIT-M), Monash University and Deakin University, Australia, have developed a cutting-edge nano-injection drug delivery platform that has the potential to make breast cancer treatment safer and more effective.

time to read

1 min

February 2026

Bio Spectrum

Agilent opens India Refurbishment Centre in Manesar

Agilent Technologies Inc., a global leader in life sciences, diagnostics, and applied chemical markets, has announced the inauguration of its India Refurbishment Centre at its LEED Platinum-certified facility in Manesar, Haryana.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Yashoda Medicity appoints Dr Rajinder Kumar as Unit Head, Department of Neurosurgery

Yashoda Medicity, one of the leading hospitals in the Delhi NCR, has appointed Prof. Dr Rajinder Kumar as Principal Director & Unit Head, Neurosurgery at the Yashoda Institute of Neurosciences.

time to read

1 min

February 2026

Translate

Share

-
+

Change font size